Search results
Find the latest news and information about Chugai, a Japanese pharmaceutical company that develops innovative medical products and services. Learn about its financial results, R&D, sustainability, and more.
- Message from the CEO
The two pillars of TOP I 2030 are “Global first-class drug...
- Chugai’s Five Strengths
In 2002, Chugai maintains its management autonomy under the...
- Company Outline
Company Outline - CHUGAI PHARMACEUTICAL CO.,LTD. |...
- Our Vision
Our Vision - CHUGAI PHARMACEUTICAL CO.,LTD. | INNOVATION...
- Our Strategy
Our Strategy - CHUGAI PHARMACEUTICAL CO.,LTD. | INNOVATION...
- History of Chugai Pharmaceutical
5. Alliance with Roche. In 2002, Chugai entered into a...
- Chugai Group
Chugai Group - CHUGAI PHARMACEUTICAL CO.,LTD. | INNOVATION...
- R&D
Chugai’s mission is to generate a steady stream of...
- Message from the CEO
Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社, Chūgai Seiyaku kabushiki gaisha) is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman.
Learn about Chugai's mission, vision, strategy, history, and group companies. Chugai is a Japanese pharmaceutical company that creates innovative drugs for the benefit of patients and partners with Roche.
As a drug manufacturer and a pioneer in biotechnological and pharmaceutical research, Chugai is a leading presence in the Japanese therapeutic antibody market and has gained reputation worldwide for its proprietary antibody engineering technologies.
3 days ago · Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Find company research, competitor information, contact details & financial data for CHUGAI PHARMACEUTICAL CO., LTD. of KITA-KU, TOKYO. Get the latest business insights from Dun & Bradstreet.
Singapore’s pool of highly skilled talent, robust intellectual property protection, and thriving public-private R&D partnerships have attracted some of the world’s leading companies to conduct innovative projects here. Tokyo-based Chugai, which specialises in prescription drugs, is among them.